Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caryn Lerman

Showing results (101-110 of 283) with videos related to

Pageof 29
Sort By:
Annals of Internal Medicine|March 17, 2004
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trialCaryn Lerman, Vyga Kaufmann, Margaret Rukstalis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapyAnna M Lee, Christopher Jepson, Peter G Shields, et al.
Psychopharmacology|February 1, 2005
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigmMargaret Rukstalis, Christopher Jepson, Andrew Strasser, et al.
Addictive Behaviors|December 13, 2017
Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017)Annie R Peng, Bernard Le Foll, Mark Morales, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2014
Working memory-related neural activity predicts future smoking relapseJames Loughead, E Paul Wileyto, Kosha Ruparel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2009
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behaviorStephen D Mague, Carolina Isiegas, Peng Huang, et al.
Archives of Internal Medicine|September 29, 2004
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutationsChanita Hughes Halbert, Henry Lynch, Jane Lynch, et al.
Health Communication|October 7, 2003
Which adolescents are most receptive to tobacco industry marketing? implications for counter-advertising campaignsJanet Audrain-McGovern, Kenneth P Tercyak, Alexandra E Shields, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Individual differences in nicotine intake per cigaretteFreda Patterson, Neal Benowitz, Peter Shields, et al.
Experimental and Clinical Psychopharmacology|February 14, 2007
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measuresAdam M Leventhal, Andrew J Waters, Susan Boyd, et al.
Pageof 29

Showing results (101-110 of 283) with videos related to

Sort By:
Pageof 29
Annals of Internal Medicine|March 17, 2004
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trialCaryn Lerman, Vyga Kaufmann, Margaret Rukstalis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2007
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapyAnna M Lee, Christopher Jepson, Peter G Shields, et al.
Psychopharmacology|February 1, 2005
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigmMargaret Rukstalis, Christopher Jepson, Andrew Strasser, et al.
Addictive Behaviors|December 13, 2017
Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017)Annie R Peng, Bernard Le Foll, Mark Morales, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2014
Working memory-related neural activity predicts future smoking relapseJames Loughead, E Paul Wileyto, Kosha Ruparel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2009
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behaviorStephen D Mague, Carolina Isiegas, Peng Huang, et al.
Archives of Internal Medicine|September 29, 2004
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutationsChanita Hughes Halbert, Henry Lynch, Jane Lynch, et al.
Health Communication|October 7, 2003
Which adolescents are most receptive to tobacco industry marketing? implications for counter-advertising campaignsJanet Audrain-McGovern, Kenneth P Tercyak, Alexandra E Shields, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Individual differences in nicotine intake per cigaretteFreda Patterson, Neal Benowitz, Peter Shields, et al.
Experimental and Clinical Psychopharmacology|February 14, 2007
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measuresAdam M Leventhal, Andrew J Waters, Susan Boyd, et al.
Pageof 29